Literature DB >> 1407589

The effect of exercise on levodopa absorption.

J H Carter1, J G Nutt, W R Woodward.   

Abstract

We studied the effect of exercise using cycle ergometry on levodopa absorption in ten patients with Parkinson's disease. Oral levodopa was administered during exercise and at rest on separate days. Exercise delayed levodopa absorption in five patients, increased it in three, and did not influence it in two. We conclude that exercise can either increase or decrease levodopa absorption.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1407589     DOI： 10.1212/wnl.42.10.2042

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  6 in total

Review 1.  How might physical activity benefit patients with Parkinson disease?

Authors:  Arlène D Speelman; Bart P van de Warrenburg; Marlies van Nimwegen; Giselle M Petzinger; Marten Munneke; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

2.  The role of exercise in facilitating basal ganglia function in Parkinson's disease.

Authors:  Giselle M Petzinger; Beth E Fisher; Garnik Akopian; Daniel P Holschneider; Ruth Wood; John P Walsh; Brett Lund; Charles Meshul; Marta Vuckovic; Michael W Jakowec
Journal:  Neurodegener Dis Manag       Date:  2011-04-01

3.  Rationale and Design of the PAIRED Trial: Partnered Dance Aerobic Exercise as a Neuroprotective, Motor, and Cognitive Intervention in Parkinson's Disease.

Authors:  Madeleine E Hackney; Allison A Bay; Jordan M Jackson; Joe R Nocera; Venkatagiri Krishnamurthy; Bruce Crosson; Marian L Evatt; Jason Langley; Xiangqin Cui; J Lucas McKay; Daniel E Huddleston
Journal:  Front Neurol       Date:  2020-10-09       Impact factor: 4.003

4.  Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa.

Authors:  J Dingemanse; K Jorga; G Zürcher; M Schmitt; G Sedek; M Da Prada; P Van Brummelen
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

Review 5.  Pharmacokinetic optimisation in the treatment of Parkinson's disease.

Authors:  M Contin; R Riva; F Albani; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

6.  Guidelines on exercise testing and prescription for patients at different stages of Parkinson's disease.

Authors:  Camilla Martignon; Anna Pedrinolla; Federico Ruzzante; Gaia Giuriato; Fabio Giuseppe Laginestra; Raquel Bouça-Machado; Joaquim J Ferreira; Michele Tinazzi; Federico Schena; Massimo Venturelli
Journal:  Aging Clin Exp Res       Date:  2020-06-08       Impact factor: 3.636
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.